News

Genentech, a biotechnology company, has reported that FDA has granted accelerated approval of Avastin for people with glioblastoma with progressive disease following prior therapy. The new indication for

Instrumentation Laboratory and its parent company Instrumentation Laboratory SpA or IL have reported that the Paris First Level Civil Court has determined that Diagnostica Stago infringed the French

As part of the agreement, AstraZeneca researchers plan to leverage the analysis application, to build biological models, analyze data, and answer biological and chemical questions in their effort

GlaxoSmithKline granted a license to Simcere in 2006 to make products containing zanamivir. Simcere is reportedly the only pharmaceutical company in mainland China that has such a license.

For the first quarter of 2009, net sales decreased 10.7% to $301.5 million from $337.7 million in the first quarter of 2008. James Foster, chairman, president and CEO

For the first quarter of 2009, the company reported net sales of $12.47 million, compared to $11.49 million for the same quarter in 2008. Ron Cohen, president and

Slater Technology Fund and other previous investors also participated in the round. The proceeds will be used to further develop NABsys’s proprietary DNA sequencing platform. Based on technology

In this new role, Dr Mueller will expand his leadership responsibilities to cover all of Vertex’s global R&D, including clinical and non-clinical development, clinical operations, medical and regulatory

According to Invitrogen, Dynabeads SSEA-4 addresses a key challenge in translational research by separating undifferentiated stem cells from those that are differentiated. Scientists from Invitrogen and the Buck